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Summary: Malaria in pregnancy is a major contributor to adverse maternal and perinatal outcome. In hyper 
endemic areas like ours, it is a common cause of anaemia in pregnancy in both immune and non-immune 
individuals and is aggravated by poor socioeconomic circumstances.  The aim of this study is to assess the 
prevalence of asymptomatic malaria parasitaemia among pregnant women in a rural setting. 272 pregnant 
women, aged between 18 and 40 years in some remote rural areas of Ebonyi State, Nigeria were recruited 
between January 2007 and March 2008.Their blood samples were collected and examined for malaria parasite, 
haemoglobin and packed cell volume using standard methods.  Our results showed 59.9% prevalence of 
parasitaemia with the highest prevalence occurring in the first trimester (84.1%).Among the positive cases, mild 
parasitaemia was recorded in 47.2% moderate parasitaemia in 37.4% while severe parasitaemia was recorded in 
15.3% of cases. These differences were statistically significant (P<0.016). Furthermore the distribution of 
malaria densities in different gravidity groups showed an inverse relationship, 45.4% in primigravidae, (31.9%) 
in secundigravidae and (10.4%) among people with more than five pregnancies. These findings were 
statistically significant (P< 0.0001). The prevalence of anaemia in pregnancy in this study was 62.4%.  Apart 
from the use of nets, drugs and vector control, the prevention of malaria in pregnancy in very poor 
socioeconomic settings should make provision for nutritional support.  
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Introduction:  
Malaria infection caused by Plasmodium 
falciparum is a major cause of fever and anaemia in 
pregnant women resident in hyper endemic areas of 
Africa. Basically, this is as a result of reduced 
immunity to malaria in pregnancy (Klufio, 1992), 
making the pregnant women prone to severe 
malaria attack and subsequently anaemia. It has 
been shown that severe anaemia was found to be 
more than twice as common in women with 
peripheral parasitaemia as in those without 
parasitaemia (Shulman et al, 1992). Indeed, malaria 
can cause several perinatal and maternal 
complications including abortion, stillbirth, low 
birth weight and even death (Brabin, 1983, 
McGregor, 1987; Nyirjesy et al, 1993). Incidentally 
malaria infection is more rampant among the 
primigravidae and secundigravidae than the 
multigravidae (Nwagha et al, 2009). The 
preferential susceptibility of these sets of pregnant 
women may be related to some evidence that 
immuno-suppression associated with pregnancy, 
occurs more in the first than subsequent 
pregnancies (Riley et al, 1989; Raheed et al, 1993). 
Previously, the depression of cell mediated immune 
response to Plasmodium falciparum antigens has 
been implicated in this phenomenon (Riley et al, 
1989). Age has also been implicated as 
epidemiological studies have shown that malaria in 
pregnancy is more prevalent in younger than older 
age groups (Bouyou-Akotet et al, 2003; Nwagha et 
al, 2009). Currently, susceptibility to Plasmodium 
parasitaemia has been linked to the level of 
antibodies to placental sequestrated parasites (Elliot 
et al, 2005). Indeed these parasites preferentially 
adhere to chondroitin sulphate-A receptors (CSA) 
expressed by the syncytiotrophoblasts in the 
placenta (Fried et al, 1998). Women in their first 
and second pregnancies are more susceptible as 
anti adhesion antibodies against CSA binding 
parasites develop after successive pregnancies 
(Duffy and Fried, 1999). The presence of parasites 
in peripheral blood without symptoms is common 
in hyper-endemic areas, and is associated with 
chronic anaemia and placental sequestration 
(Nwagha et al, 2009). 
Malaria infection during pregnancy 
contributes significantly to anaemia in pregnancy 
and low birth weight babies (Deen et al, 2001). 
Antenatal anaemia has shown positive correlation 




mortality rate (IMR). Indeed, the use of effective 
anti-malarial drugs during pregnancy has been 
found to lower the frequency of LBW and reduce 
IMR (Steketee et al, 1996; Verhoeff et al, 1998; 
Kayentoa et al, 2005).  
The prevention of malaria in pregnancy 
includes intermittent preventive treatment (IPT), in 
which full dose of a drug is given at defined 
intervals. IPT has been shown to have the potential 
to provide some of the benefits of sustained 
prophylaxis in pregnant women, and it is a 
promising approach to malaria control (Kayentoa et 
al, 2005; Falade et al, 2007). The use of insecticide 
treated net (ITN) has also been advocated and has 
shown potential efficiency in the control of 
mosquito bites. However, it is certain that a 
pregnant woman cannot remain under the net for 
more than 8 hours a day; hence it does not give 
complete protection against malaria (Nwagha et al, 
2009). Moreover sulphadoxine-pyrimethamine 
(SP), which has gradually replaced chloroquine 
(CQ) as the first line treatment for malaria in some 
parts of Africa, is already beginning to show 
reasonable failure rate (Briand et al, 2007). In a 
rural environment with poor nutritional support, the 
impact of the adverse effect of malaria and anaemia 
in pregnancy will be enormous, thus additional 
measures should be advocated. In this study we 
assessed the prevalence of malaria parasitaemia in 
pregnant women in a rural area of Ebonyi State of 
Nigeria and advocate for a collective approach to 
malaria prevention and treatment in malaria 
endemic areas.  
 
Materials and Methods 
 
Study Area, Study Design and Methodology 
Study Area 
Ebonyi State was created in 1996 from the old 
Enugu and Abia States. The state shares boundaries 
with Cross River state in the east, Enugu state in 
the west, Abia state in the south and Benue state in 
the north. It has a land mass of about of 5932 
square kilometers, and consists of 13 local 
government areas with a projected population of 
about 2.2 million out of which about 52% are 
females. It is considered as one of the educationally 
disadvantaged states in Nigeria. Ngbo community 
is in Ohaukwu local Government area of Ebonyi 
state with an estimated population of about one 
hundred and ninety six thousand (196,000). There 
is no public water or light supply in this 
community. Source of drinking water is stream and 
toilet facilities are either bush or pit toilet. Major 
occupation is mainly subsistent farming with a few 
people doing petty trading. Christianity and African 
traditional religion form their major religious 
beliefs. The health centers used in this study have 
only one trained midwife each assisted by locally 
trained birth attendants. Facilities for blood 
banking were unavailable Subject 
This is cross sectional study involving 272 
pregnant women, aged between 18 and 40 years. 
After obtaining ethical clearance from the relevant 
body, apparently healthy pregnant women 
attending antenatal clinic, who were not on any 
form of malaria prophylaxis were counseled, oral 
informed consent obtained and were recruited by 
simple random sampling using a lucky dip of Yes 
or No. They were from the antenatal clinics of two 
rural health centers of Ngbo in Ohaukwu local 
Government area of Ebonyi State of Nigeria. Out 
of this number, 44 were in the first trimester, 82 in 
the second trimester while the remaining 146 were 
in the last trimester. Also, 126 of this number were 
either primigravidae or secundigravidae while the 
remaining were multigravidae.Patients that had 
symptoms indicating malaria, example; fever, 
headache, weakness, anorexia and joint/muscle 
pains were excluded from the study. Also excluded 
were subjects who had some form of antimalaria 
drugs in the index pregnancy and who slept in 
ITNs. Other exclusions include human 
immunodeficiency virus (HIV) positive patients, 
sickle cell disease, diabetes mellitus, hypertension 
and any other diagnosed medical condition in 
pregnancy. We wanted to exclude the possible 
effect these variables will have on the body’s 
response to the presence of malaria parasite. All the 
subjects were of low socioeconomic status 
(subsistent farmers and petty traders).  
Personal history, history of present pregnancy, 
past obstetric history, past medical history, family 
and social history and review of systems were 
obtained. The gestational age was assessed from 
the last normal menstrual period. The expected date 
of delivery was calculated using the Naegele’s rule. 
This rule is a pregnancy due date calculator named 
after a German Obstetrician who devised the rule 
.It calculates approximately the Expected Date of 
Delivery (EDD) from the first day of the woman's 
Last Menstrual Period (LMP). It is done by totaling 
a year, deducting three months from that year and 
adding up seven days (Cunninghams et al, 1989). 
Trimester was defined as first trimester (< 14 
weeks), second (14 weeks -27 weeks) and third (> 
27weeks).  
Medical and obstetric examinations were 
done. Axillary temperature was taken to exclude 
fever and temperature of less than 37.5
o
C was 
considered as normal. The antenatal laboratory 
investigations, as done in our center include; 
Genotype, Screening for syphilis, hepatitis B and 
HIV, were normal. In our environment, HIV 
screening is done for all pregnant women.  
 
Laboratory Methods 
After cleaning the volar surface of the arm 
with cotton wool moistened with methylated spirit, 




peripheral blood samples were collected in sterile 
containers. Thin and thick blood smears were made 
from each of these samples, stained with Geimsa 
and then examined under the microscope using 
x100 objective lens in each case. Identification of 
species was done using the thin blood smear. The 
parasite density was estimated on the thick smear 
under oil immersion and viewed using x100 
objective lens. The determination was by counting 
the number of asexual forms of Plasmodium 
falciparum parasites against at least 100 leucocytes 
and 200 leucocytes for definitive count. The 
number of asexual parasites was calculated using 
this formula 
 
Parasites/ưL=   No of asexual parasites x 8000 
leucocytes/200 leucocytes  
 
The degree of parasitaemia was graded thus (1-999/ 
ưL) as mild or +,(1000-9999 /ưL) as moderate or 
++,and (>10000/ ưL) as severe or +++. 
 
A negative result was recorded after thorough 
examination of 100 fields without any parasite. 
Quality control was ensured by using freshly 
reconstituted and filtered Geimsa stains. The 
microscopist is very experienced and spent an 
average of 15 minutes to one hour on each thick 
and thin film respectively. Comparison was made 
with both known positive and negative thin films.    
Samples were also estimated for PCV using the 
microhaematocrit centrifugation while hemoglobin 
concentration was estimated 
spectrophotometrically using the 
cyamethaemoglobin method (Chesbrough 2000). 
All laboratory analyses were done on the day of 
sample collection except microscopy. All the 
patients with malaria parasites and anaemia were 
promptly and adequately treated free of charge.  
 
Statistical analysis 
This was done using SPSS version 11 
computer software. Results were presented as 
simple percentages. Test for significance was done 
using Chi square and ANOVA where applicable. P 





Table 1 shows the prevalence of malaria 
parasite among number and duration of 
pregnancies. Out of 272 subjects studied, a total of 
163 were positive showing a total prevalence of 
59.9%.Among a total of 124 Primigravidae, 74 
tested positive; a prevalence of 59.7%. 
Secundigravidae recorded a prevalence of  59.8%, 
while that  for multigravidae was  about 60%.  
Furthermore, malaria parasitaemia was more 
common in the first trimester (84.1%), followed by 
the second trimester (75.6%) and then third 
trimester (43.8%). The relative distribution of 
malaria densities in the various trimester and 
gravidity groups is shown in Table 2.  Among the 
positive cases, mild parasitaemia was recorded in 
77 (47.2%) moderate parasitaemia in 61 (37.4%) 
while severe parasitaemia was recorded in 25 
(15.3%) of cases. These differences were 
statistically significant (Chi square 8.331.P=0.016). 
The distribution of malaria densities in different 
gravidity groups shows that among all positive 
cases, 74 (45.4%) occurred in primigravidae while 
secundigravidae recorded 52 (31.9%). The least 
occurred in people with more than five pregnancies 
17 (10.4%). These findings were statistically 
significant (Chi square 54.644, P <0.0001). The 
prevalence of anaemia in pregnancy in this study 
was 62.4%. This is based on the definition of 
anaemia in pregnancy in our environment which is 
PCV of less than 30% (Ogunbode, 1984).  
However among the 163 that were positive for 
malaria parasite; we calculated the mean PCV and 
haemoglobin. This was then matched against the 
malaria parasite densities and different trimesters as 
shown in Table 3. There were statistically decrease 
in the PCV and Hb as malaria density increased 





Table 1: Prevalence of asymptomatic malaria 
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Table 2; Malaria Parasites densities showing 
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Table 3: Mean hemoglobin and PCV showing 








Parasitemia   
Mild(n=77) 28.4±3.2 9.6±1.8 
Moderate(n=61) 27.8±4.5 9.5±1.2 
Severe(n=25) 26.9±4.0 9.3±1.1 
Trimester   
First(n=35) 27.8±4.6 9.5±1.1 
Second(n=62) 26.9±2.6 9.4±1.3 




A prevalence of 59.9% of malaria 
parasitaemia obtained from our study is comparable 
to previous work done in other areas; 57% in 
Libreville, Gabon (Bouyou-Akotet et al, 2003), 
63.5% in Awka, Nigeria in 2003 (Chukwurah et al, 
2003) and 58.4% in Enugu (Nwagha et al, 2009). 
Contrary to findings from other studies (Nair et al, 
1993; Rogerson et al, 2000; Anorlu et al, 2001; 
Nwagha et al, 2009),   we found no significant 
changes in prevalence among parity groups. This 
may be unrelated to the comparatively small 
number of subjects recruited as parity increased. 
However when we pooled all the positive cases, it 
became obvious that susceptibility was more in 
primigravidae.  Furthermore, asymptomatic malaria 
parasitaemia occurred more in the first and second 
trimesters than third trimester. This is similar to 
other studies which showed that susceptibility is 
more marked in the second trimester than during 
the third trimester (Brabin, 1983; Nwagha et al, 
2009).  The prevalence of anaemia in pregnant 
Nigerian women in this study was 62.4% using our 
local standard (Ogunbode, 1984). Other studies 
also recorded high prevalence rates (Bouyou-
Akotet et al, 2003; Brabin et al, 2004; Nwagha et 
al, 2009,).  Furthermore, PCV and Hb showed a 
significant decrease with increasing parasite 
density. This is understandable as increasing 
parasite density ultimately leads to increase in red 
cell breakdown and consequently anaemia. This is 
aggravated by the poor socio-economic background 
of the patients since they are predominantly 
subsistent farmers. This situation calls for proper 
evaluation of the nutritional status of our rural 
pregnant women so as to assist pregnancy care 
givers double their efforts in malaria prevention. 
ITN, IPT, integrated vector control and 
nutritional support as well as health education 
should be used concurrently in the prevention of 
the adverse effect of malaria in pregnancy. Indeed 
IPT has been shown to reduce maternal peripheral 
parasitaemia (Van Ejik et al, 2002), placental 
parasitization (Rogerson et al, 2000; Deen et al, 
2001; Van Ejik et al, 2002), low birth weight 
(Verhoeff, 1998; Rogerson, 2000) and maternal and 
neonatal anaemia (Steketee et al, 1996). Indeed, the 
use of IPT is also indispensable as frequency of 
fever has not correlated well with incidence and 
density of malaria. It has been shown that 24.4% of 
parasitaemic and 25.4% aparasitaemic pregnant 
women had fever before their first antenatal clinic 
visits, giving sensitivity and specificity of fever to 
identify parasitaemia as 24% and 71% respectively 
(Steketee et al, 1996).   
This prospective study was successfully 
completed in a local community with a difficult 
socio-topographic environment, irrespective of the 
usual difficulties encountered during community 
auditing in Nigeria. However, it would have been 
more appropriate if we had followed up these 
patients until delivery to enable us assess the 
impact of asymptomatic parasitaemia on feto-
maternal outcome. This will be addressed in future 
studies.   
This study illustrates a high prevalence of 
asymptomatic plasmodium parasitaemia and 
anaemia in pregnant rural Nigerian women. Apart 
from IPT and ITN, efforts should be made to 
incorporate other vector control measures in the 
context of integrated vector control. The rural areas 
will benefit from efforts at larva control and 
reduction of breeding sites like bushes near living 
homes. Concerted efforts to reduce poverty, 
improve nutrition, housing and electricity in the 
rural areas of Nigeria will invariably reduce the 
malaria burden. This will go a long way in reducing 
maternal and perinatal morbidity and mortality. 
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